An arginine to cysteine(252) mutation in insulin receptors from a patient with severe insulin resistance inhibits receptor internalisation but preserves signalling events

scientific article (publication date: May 2002)

An arginine to cysteine(252) mutation in insulin receptors from a patient with severe insulin resistance inhibits receptor internalisation but preserves signalling events is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1010780145
P356DOI10.1007/S00125-002-0798-5
P698PubMed publication ID12107746
P5875ResearchGate publication ID11270247

P50authorC. Ronald KahnQ16106681
P2093author name stringM Foti
P De Meyts
J Philippe
R Emkey
M Cordier-Bussat
C Maeder
I Hamer
J-L Carpentier
P2860cites workRASMOL: biomolecular graphics for allQ29547757
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectpatientQ181600
preproinsulinQ7240673
insulin resistanceQ1053470
P304page(s)657-67
P577publication date2002-05-01
P1433published inDiabetologiaQ5270140
P1476titleAn arginine to cysteine(252) mutation in insulin receptors from a patient with severe insulin resistance inhibits receptor internalisation but preserves signalling events
P478volume45

Reverse relations

cites work (P2860)
Q31085376A novel mutation causing nephronophthisis in the Lewis polycystic kidney rat localises to a conserved RCC1 domain in Nek8
Q24297068Activation of the insulin receptor by insulin and a synthetic peptide leads to divergent metabolic and mitogenic signaling and responses
Q41866412Association of keratin 8/18 variants with non-alcoholic fatty liver disease and insulin resistance in Chinese patients: A case-control study
Q43264830Beneficial effects of L-arginine against diabetes-induced oxidative stress in gastrointestinal tissues in rats
Q36470497Clustering of genetically defined allele classes in the Caenorhabditis elegans DAF-2 insulin/IGF-1 receptor
Q78621007Current literature in diabetes
Q46138751Differential endocytosis and signaling dynamics of insulin receptor variants IR-A and IR-B.
Q53691018Evaluation of anti-insulin receptor antibodies as potential novel therapies for human insulin receptoropathy using cell culture models.
Q34768512Founder effect in the Horn of Africa for an insulin receptor mutation that may impair receptor recycling
Q30538044Insulin and insulin like growth factor II endocytosis and signaling via insulin receptor B
Q43097788Insulin receptor membrane retention by a traceable chimeric mutant
Q39640027Insulin receptor trafficking steers insulin action
Q35824181Ligand-Binding Affinity at the Insulin Receptor Isoform-A and Subsequent IR-A Tyrosine Phosphorylation Kinetics are Important Determinants of Mitogenic Biological Outcomes
Q33343449Model-based hypothesis testing of key mechanisms in initial phase of insulin signaling
Q21131281Molecular basis of signaling specificity of insulin and IGF receptors: neglected corners and recent advances
Q37403947Molecular mechanisms of differential intracellular signaling from the insulin receptor
Q33471497Rapid insulin-dependent endocytosis of the insulin receptor by caveolae in primary adipocytes
Q33796356Reciprocal regulation of endocytosis and metabolism
Q91995634Requirement for translocon-associated protein (TRAP) α in insulin biogenesis
Q34491332Rin1 regulates insulin receptor signal transduction pathways
Q44129445Role of two dileucine-like motifs in insulin receptor anchoring to microvilli
Q29393863Sequencing analysis of insulin receptor defects and detection of two novel mutations in INSR gene
Q34152764Structural biology of insulin and IGF1 receptors: implications for drug design
Q54324866[Involvement of the endosomal compartment in cellular insulin signaling].

Search more.